Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Jubilant Ingrevia Ltd
-(JUBLINGREA)
XNSE:JUBLINGREA, XBOM:JUBLINGREA
Jubilant Ingrevia Ltd Q4FY24; 44% fall in Profits
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Jubilant Ingrevia Ltd Q3FY24; 58% fall in Profits
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Jubilant Ingrevia Ltd Q2FY24; 32% fall in Profits
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Jubilant Ingrevia Ltd Q1 FY24; 27% fall in Profits
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Jubilant Ingrevia Ltd (JUBLINGREA) Q4 FY23 Earnings Concall Transcript
Jubilant Ingrevia Ltd (NSE:JUBLINGREA) Q4 FY23 Earnings Concall dated May. 16, 2023. Corporate Participants: Pavleen Singh Taneja -- Director, Investor Relations Shyam S. Bhartia -- Chairman
Jubilant Ingrevia Q4FY23 Earnings Story
Jubilant Ingrevia is a provider of integrated global life science products and innovative solutions. We cater to customers in the pharmaceutical, nutrition,
Earnings Summary Of Jubilant Ingrevia Limited For Q3 FY23
Jubilant Ingrevia Limited (NSE: JUBLINGREA) is an integrated pharmaceutical and life sciences company headquartered in Noida, India. The company operates in the
Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY23 Earnings Concall Transcript
Jubilant Ingrevia Ltd (NSE:JUBLINGREA) Q3 FY23 Earnings Concall dated Jan. 31, 2023. Corporate Participants: Pavleen Singh Taneja -- Investor Relations Shyam Bhartia -- Chairman Rajesh Srivastava -- Chief
Jubilant Ingrevia Ltd Q2 FY23 Earnings Conference Call Insights
[youtube https://www.youtube.com/watch?v=zEZQ7mQGxGM&showinfo=0] Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q2 FY23 Earnings Concall Management Update: [00:10:34] JUBLINGREA expects its 2H23 performance to
Jubilant Ingrevia Ltd (JUBLINGREA) Q2 FY23 Earnings Concall Transcript
Jubilant Ingrevia Ltd (NSE:JUBLINGREA) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate Participants: Pavleen Singh Taneja -- Director, Investor Relations Shyam
Jubilant Ingrevia Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/q-jII_ukXcc Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q4 FY22 Earnings Concall Management Update: JUBLINGREA said it recorded the highest ever revenue
Jubilant Ingrevia Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=VEV5IjVrTNI Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY22 Earnings Concall Management Update: JUBLINGREA commented that with its capex plans shaping